Loading…
Alzamend Neuro, Inc. is projected to decline to $1.13 by 2027, a -4% move from its current price of $1.18. ALZN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.14 | $1.18 | $1.22 | +0.01% |
| Jul 14 | $1.12 | $1.18 | $1.24 | +0.01% |
| Jul 15 | $1.11 | $1.18 | $1.25 | +0.02% |
| Jul 16 | $1.10 | $1.18 | $1.27 | +0.03% |
| Jul 17 | $1.09 | $1.18 | $1.28 | +0.03% |
| Jul 18 | $1.08 | $1.18 | $1.29 | +0.04% |
| Jul 19 | $1.08 | $1.18 | $1.30 | +0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.08 | $1.18 | $1.30 | +0.05% |
| Week 2 | $1.04 | $1.18 | $1.35 | +0.09% |
| Week 3 | $1.01 | $1.18 | $1.39 | +0.14% |
| Week 4 | $0.9809 | $1.18 | $1.42 | +0.19% |
| Week 5 | $0.96 | $1.18 | $1.46 | +0.23% |
| Week 6 | $0.9415 | $1.18 | $1.49 | +0.28% |
| Week 7 | $0.9248 | $1.18 | $1.52 | +0.33% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company focused on developing products for the treatment of neurodegenerative and psychiatric disorders.
Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease.
Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
ALZN trades at $1.20 per share.
Its market cap is $4.57M and it ranks 5319.
The technical setup shows bullish sentiment with RSI14 at 60. Moving averages stand at SMA50 of $1.13 and SMA200 of $1.85. The stock has a defined 30-day range and key support and resistance levels at $1.01 and $1.37, respectively.
A major floor 27.3% below — a decisive break under it would weaken the trend.
The nearest floor, 5.9% below — buyers have tended to step in here.
The nearest ceiling, 16.1% above — a clean break opens room to run.
A major ceiling 84.7% above — clearing it would confirm fresh momentum.
Key ALZN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ALZN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.16 | Buy | $1.17 | Buy |
| MA 10 | $1.16 | Buy | $1.18 | Buy |
| MA 20 | $1.21 | Sell | $1.18 | Sell |
| MA 50 | $1.15 | Buy | $1.21 | Sell |
| MA 100 | $1.35 | Sell | $1.39 | Sell |
| MA 200 | $1.79 | Sell | $3.23 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.65 | Neutral |
| Stoch RSI (14) | 24.78 | Neutral |
| CCI (20) | -37.68 | Neutral |
| Williams %R (14) | -76.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -13.87 | Sell |
| Bollinger %B (20,2) | 0.39 | Neutral |
| Stochastic %K (14) | 24.00 | Neutral |
| TRIX (15) | 0.14 | Buy |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 45.77 | Neutral |
| Momentum (10) | -0.11 | Sell |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 1.16 | Buy |
| ADX (14) | 10.89 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day picture carries bullish undertones, with RSI14 at 60 supporting ongoing upside momentum.
The price has support near $1.01 and resistance near $1.37, with the 50-day moving average at $1.13 and the 200-day moving average at $1.85. The 30-day range spans from $0.9217 to $1.56, reflecting some volatility within a relatively tight band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.858 | $1.18 | $1.56 | 0% | Neutral | |
| $0.8768 | $1.13 | $1.56 | -4% | Neutral | |
| $0.8114 | $1.09 | $1.57 | -8% | Neutral | |
| $0.7299 | $1.01 | $1.51 | -14% | Neutral | |
| $0.8012 | $1.14 | $1.75 | -4% | Neutral | |
| $0.9635 | $1.40 | $2.22 | +19% | Neutral | |
| $0.9388 | $1.40 | $2.27 | +19% | Neutral | |
| $0.8899 | $1.36 | $2.24 | +15% | Neutral | |
| $0.8132 | $1.27 | $2.14 | +8% | Neutral | |
| $0.8174 | $1.30 | $2.23 | +10% | Neutral | |
| $0.9215 | $1.61 | $2.98 | +37% | Bullish | |
| $1.66 | $3.45 | $7.07 | +192% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.858 | $1.18 | $1.39 | +0.00% |
| August 2026 | $0.9849 | $1.17 | $1.44 | -0.72% |
| September 2026 | $0.989 | $1.19 | $1.48 | +1.34% |
| October 2026 | $0.9496 | $1.15 | $1.45 | -3.22% |
| November 2026 | $0.944 | $1.15 | $1.46 | +0.07% |
| December 2026 | $0.9904 | $1.21 | $1.56 | +5.57% |
Click any year to see its month-by-month ALZN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ALZN is projected to trade between $0.858 and $1.56, averaging $1.18 — a potential gain of 0% from today's $1.18. Price action looks broadly range-bound.
Alzamend Neuro, Inc.'s 2027 outlook centres on $1.13, within a $0.8768 to $1.56 range. That is -4% versus the projected 2026 average. That marks a -4% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, ALZN could reach as high as $1.57, with a base case around $1.09 and support toward $0.8114 — roughly -8% from $1.18. Price action looks broadly range-bound.
Expect ALZN to range from $0.7299 to $1.51 through 2029. The $1.01 average target implies a -14% move from current prices. That is -7% versus the projected 2028 average. A consolidation phase looks the most probable path here.
The ALZN price prediction for 2030 points to an average of $1.14 (low $0.8012, high $1.75) — a potential decline of -4% on today's $1.18. Price action looks broadly range-bound.
In 2031, ALZN is projected to trade between $0.9635 and $2.22, averaging $1.40 — a potential gain of +19% from today's $1.18. That is up +23% on the projected 2030 average. A consolidation phase looks the most probable path here.
Alzamend Neuro, Inc.'s 2032 outlook centres on $1.40, within a $0.9388 to $2.27 range. That is 0% versus the projected 2031 average. That marks a +19% change versus current levels. Price action looks broadly range-bound.
By 2033, ALZN could reach as high as $2.24, with a base case around $1.36 and support toward $0.8899 — roughly +15% from $1.18. A consolidation phase looks the most probable path here.
Expect ALZN to range from $0.8132 to $2.14 through 2034. The $1.27 average target implies a +8% move from current prices. That is -7% versus the projected 2033 average. Price action looks broadly range-bound.
The ALZN price prediction for 2035 points to an average of $1.30 (low $0.8174, high $2.23) — a potential gain of +10% on today's $1.18. A consolidation phase looks the most probable path here.
In 2040, ALZN is projected to trade between $0.9215 and $2.98, averaging $1.61 — a potential gain of +37% from today's $1.18. That is up +24% on the projected 2035 average. Momentum favours further upside here.
Alzamend Neuro, Inc.'s 2050 outlook centres on $3.45, within a $1.66 to $7.07 range. That is up +114% on the projected 2040 average. That marks a +192% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in ALZN today (≈ 847.457627 ALZN) could be worth
$2,921.89
+$1,921.89 (+192%) by 2050 · US Dollar
Based on the average projected ALZN price of $3.45 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ALZNwould be worth at today's price.
$1,000 invested in ALZN on Jul 10, 2025 (≈ 327.868858 ALZN) would be worth
$386.89
-$613.11 (-61.3%) today · 0.39× · US Dollar
Based on a ALZN entry price of $3.05 vs. today's $1.18.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.16 | $1,017.24 | +1.7% |
| 1 month ago | $1.16 | $1,017.24 | +1.7% |
| 3 months ago | $0.858 | $1,375.29 | +37.5% |
| 6 months ago | $2.33 | $506.44 | -49.4% |
| 1 year ago | $3.05 | $386.89 | -61.3% |
| All time (5.0y) ago | $8,370 | $0.14 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ALZN forecast.
Our base-case forecast reaches $2.40 around 2050.
Implied market cap at $2.40: $9.13M
In the near term, the forecast points to a neutral stance around 2026 with an average price of $1.20 and an ROI of 0%, followed by softer near-term years such as 2027 (avg $1.11, ROI -7.9%) and 2028 (avg $1.09, ROI -9.4%), then continuing a neutral stance for 2029 (avg $1.01, ROI -16%). The 2030 forecast shows a return to a modest level (avg $1.14, ROI -5%).
From 2031 onward, the outlook turns more favorable: 2031 (avg $1.48, ROI 22.9%, sentiment BULLISH) and 2032 (avg $1.42, ROI 18.3%, sentiment NEUTRAL) reflect improving momentum, with steady levels through 2033–2035 (avg $1.32–$1.30, ROI 8–10%, sentiment NEUTRAL).
The long-range forecast strengthens significantly later, with 2040 (avg $1.61, ROI 34.2%, sentiment BULLISH) and 2050 (avg $3.55, ROI 195.7%, sentiment BULLISH) signaling meaningful upside potential, albeit with ongoing volatility and uncertainty.
Tap a question to reveal the answer.
Avg price $1.14, min $0.7757, max $1.82, ROI -5, sentiment NEUTRAL.
Forecasts show neutral momentum in the near term with potential upside emerging in the 2031–2050 window (2031 avg $1.48, ROI 22.9%, sentiment BULLISH; 2050 avg $3.55, ROI 195.7%, sentiment BULLISH). These are estimates, not guarantees, and may vary with market conditions.
The max forecast by 2050 is $7.70, indicating the possibility of reaching above $5 in the long term.
Low $0.9217, High $1.56.
Current price $1.20; Market cap $4.57M.
Alzamend Neuro, Inc. Community Discussion
0Share your Alzamend Neuro, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.